Leo
Lv51
1068 积分
2024-10-08 加入
-
Discovery of Edecesertib (GS-5718): A Potent, Selective Inhibitor of IRAK4
4小时前
待确认
-
Hidradenitis suppurativa
4小时前
待确认
-
Influence of urinary creatinine concentration and specific gravity correction in exposure assessment: Comparison between chronic kidney disease patients and general population
9天前
已完结
-
[Guidelines on the management of ascites in cirrhosis (2023 version)]
15天前
已完结
-
Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects
20天前
已完结
-
Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol
30天前
已完结
-
Effects of Food and Multiple‐dose Administration on the Pharmacokinetic Properties of HR20033, a Sustained‐release Formulation of Henagliflozin and Metformin for the Treatment of Diabetes, in Healthy Chinese Volunteers
1个月前
已完结
-
Hypertension in China: epidemiology and treatment initiatives
1个月前
已完结
-
Pharmacokinetic drug-drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol
1个月前
已完结
-
Pharmacokinetics and safety of sacubitril/valsartan (LCZ696) in patients with mild and moderate hepatic impairment
2个月前
已完结